Date: June 19, 2013
Summary:
WASHINGTON – Today, U.S. Reps. Diana DeGette (D-CO) and Charlie Dent (R-PA) introduced the bipartisan Stem Cell Research Advancement Act, to ensure a lasting framework for ethical embryonic stem cell research at the National Institutes for Health (NIH), and to bring certainty to the scientific community pursuing research that could produce life-saving cures and treatments.
The Stem Cell Research Advancement Act would support embryonic stem cell research, and codify the NIH’s guidelines for carrying out all human stem cell research, embryonic and adult. It also requires NIH to review its guidelines at least every three years and make periodic updates as scientifically warranted.
WASHINGTON – Today, U.S. Reps. Diana DeGette (D-CO) and Charlie Dent (R-PA) introduced the bipartisan Stem Cell Research Advancement Act, to ensure a lasting framework for ethical embryonic stem cell research at the National Institutes for Health (NIH), and to bring certainty to the scientific community pursuing research that could produce life-saving cures and treatments.
The Stem Cell Research Advancement Act would support embryonic stem cell research, and codify the NIH’s guidelines for carrying out all human stem cell research, embryonic and adult. It also requires NIH to review its guidelines at least every three years and make periodic updates as scientifically warranted.
